BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
29.04.23
/
50%
€88.08
Target price
29.04.24
-
Performance (%)
-13.03%
End price
30.04.24
€76.60
Summary
This prediction ended on 30.04.24 with a price of €76.60. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.03%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -2.509% | -2.509% | -12.096% |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten